47 related articles for article (PubMed ID: 21699469)
1. Nitric oxide: a new biomarker of Doxorubicin toxicity in children?
Guler E; Baspinar O; Cekmen M; Kilinc M; Balat A
Pediatr Hematol Oncol; 2011 Aug; 28(5):395-402. PubMed ID: 21699469
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.
Minotti G; Mancuso C; Frustaci A; Mordente A; Santini SA; Calafiore AM; Liberi G; Gentiloni N
J Clin Invest; 1996 Aug; 98(3):650-61. PubMed ID: 8698856
[TBL] [Abstract][Full Text] [Related]
3. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
4. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
[TBL] [Abstract][Full Text] [Related]
5. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin and total nitrite levels in children with familial Mediterranean fever.
Balat A; Işlek I; Cekmen M; Yürekli M; Tekin D; Muslu A; Sahinöz S
J Paediatr Child Health; 2006 May; 42(5):240-3. PubMed ID: 16712551
[TBL] [Abstract][Full Text] [Related]
8. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
9. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
Ekstein S; Nir A; Rein AJ; Perles Z; Bar-Oz B; Salpeter L; Algur N; Weintraub M
J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
[TBL] [Abstract][Full Text] [Related]
10. Nitrite plasma levels in acute and chronic coronary heart disease.
Ferlito S; Gallina M
Minerva Cardioangiol; 1997 Nov; 45(11):553-8. PubMed ID: 9549288
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer.
Guldner L; Haddy N; Pein F; Diallo I; Shamsaldin A; Dahan M; Lebidois J; Merlet P; Villain E; Sidi D; Sakiroglu O; Hartmann O; Leftakopoulos D; de Vathaire F
Radiother Oncol; 2006 Oct; 81(1):47-56. PubMed ID: 16989913
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
[TBL] [Abstract][Full Text] [Related]
13. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma nitrite level in cardiac failure.
Ramesh G; Varma JS; Ganguly NK; Dhawan V; Bali HK; Singh M
J Mol Cell Cardiol; 1999 Aug; 31(8):1495-500. PubMed ID: 10423347
[TBL] [Abstract][Full Text] [Related]
16. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C
Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
[TBL] [Abstract][Full Text] [Related]
17. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin and total nitrite levels in children with acute rheumatic fever.
Balat A; Kilinç M; Cekmen MB; Güler E; Yürekli M; Sahinöz S; Coşkun Y
Clin Biochem; 2005 Jun; 38(6):526-30. PubMed ID: 15885231
[TBL] [Abstract][Full Text] [Related]
19. Subclinical cardiotoxicity by doxorubicin: a pulsed Doppler echocardiographic study.
Cittadini A; Fazio S; D'Ascia C; Basso A; Bazzicalupo L; Picardi G; Saccà L
Eur Heart J; 1991 Sep; 12(9):1000-5. PubMed ID: 1935999
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
Nousiainen T; Vanninen E; Jantunen E; Remes J; Ritanen E; Vuolteenaho O; Hartikainen J
Clin Sci (Lond); 2001 Dec; 101(6):601-7. PubMed ID: 11724646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
